http://www.abbvie.com
AbbVie Inc. Company Intro
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
Industry
Healthcare
AbbVie Inc. Headquaters
1 North Waukegan Road
North Chicago,60064
United States
AbbVie Inc. Share price
22 Oct 2020 01:00 GMT
$83.58
-0.67 (-0.8 %)
AbbVie Inc. Market cap
$146.287 B
WMC RANKING
2020
AbbVie Inc. # 3
Drug Manufacturers—GeneralLatest AbbVie Inc. News
22 Oct 2020
MRI Safe Implantable Device Market To Witness A Considerable CAGR Growth Through The Forecast Period 2016 – 2024
... Laboratories, Cochlear Ltd., Biotronik, Boston Scientific Corporation, St. Jude Medical Inc, Smiths Medical, AbbVie, Inc., TriVascular2, Inc. Stryker Corporation, ...
22 Oct 2020
Salivary Gland Infection Market Report Provide the ...
AbbVie Inc. (US). Allergan (Republic of Ireland). AstraZeneca (UK). FUJIFILM Holdings Corporation (Japan). General Electric Company (US). GlaxoSmithKline ...
22 Oct 2020
Global Antiretroviral Drugs Market 2020 – Comprehensive ...
AbbVie Inc. Boehringer Ingelheim Mylan Merck & Co. Bristol-Myers Squibb Johnson & Johnson ViiV Healthcare Cipla Gilead Sciences Inc. A SWOT analysis is ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| AbbVie Inc. | 42.12 | 7.16 | 89.06 | 0 | 0 | 0 | 41.99 |
| Johnson & Johnson | 100 | 100 | 29.38 | 100 | 0 | 0 | 100 |
| Merck & Co., Inc. | 58.37 | 20.68 | 37.5 | 0 | 0 | 0 | 25.38 |
| AstraZeneca PLC | 31.78 | 23.63 | 10.94 | 2 | 0 | 0 | 15.78 |
| Amgen Inc. | 30.05 | 10.78 | 100 | 0 | 0 | 0 | 48.32 |
AbbVie Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| AbbVie Inc. | $34,057,000 | $12,564,000 | $8,394,000 | $148.687B | 3 |
| Johnson & Johnson | $80,856,000 | $33,169,000 | $16,986,000 | $380.574B | 1 |
| Merck & Co., Inc. | $47,194,000 | $20,494,000 | $10,479,000 | $197.964B | 2 |
| AstraZeneca PLC | $25,699,000 | $17,950,000 | $2,148,000 | $105.85B | 4 |
| Amgen Inc. | $24,301,000 | $9,809,000 | $7,299,000 | $135.354B | 5 |